IBM Retirement Fund’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,400
Closed -$930K 307
2022
Q1
$930K Sell
5,400
-235
-4% -$39.6K 0.13% 143
2021
Q4
$1.43M Sell
5,635
-3,936
-41% -$1.15M 0.18% 101
2021
Q3
$3.68M Buy
9,571
+22
+0.2% +$8.11K 0.29% 61
2021
Q2
$2.24M Sell
9,549
-182
-2% -$32.5K 0.18% 106
2021
Q1
$1.27M Sell
9,731
-854
-8% -$124K 0.09% 195
2020
Q4
$1.11M Buy
10,585
+1,308
+14% +$132K 0.08% 234
2020
Q3
$656K Buy
9,277
+2,999
+48% +$209K 0.06% 292
2020
Q2
$403K Buy
+6,278
New +$344K 0.05% 312

Other funds holding MRNA

IBM Retirement Fund's MRNA Position: Q2 2022 in Review

IBM Retirement Fund sold out of Moderna (MRNA) in Q2 2022, closing a stake of 5,400 shares — an estimated $930K sold.

IBM Retirement Fund first reported a position in MRNA in Q2 2020 and held it in 8 quarters. The position peaked at $3.68M in Q3 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • IBM Retirement Fund reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • IBM Retirement Fund sold 5,400 Moderna shares in Q2 2022, an estimated $930K.
  • IBM Retirement Fund first reported a position in Moderna in Q2 2020 and held it in 8 quarters.
  • IBM Retirement Fund's Moderna position peaked at $3.68M in Q3 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on IBM Retirement Fund's 13F filing for Q2 2022, filed 20 Jul 2022.